Correction: Transforming growth factor α expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines (Cancer Research (2006) 66, 7, (3802-3812))
Publication
, Journal Article
Pino, MS; Shrader, M; Baker, CH; Cognetti, F; Xiong, HQ; Abbruzzese, JL; McConkey, DJ
Published in: Cancer Research
January 15, 2010
Duke Scholars
Published In
Cancer Research
DOI
EISSN
1538-7445
ISSN
0008-5472
Publication Date
January 15, 2010
Volume
70
Issue
2
Start / End Page
852 / 853
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Pino, M. S., Shrader, M., Baker, C. H., Cognetti, F., Xiong, H. Q., Abbruzzese, J. L., & McConkey, D. J. (2010). Correction: Transforming growth factor α expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines (Cancer Research (2006) 66, 7, (3802-3812)). Cancer Research, 70(2), 852–853. https://doi.org/10.1158/0008-5472.CAN-09-4221
Pino, M. S., M. Shrader, C. H. Baker, F. Cognetti, H. Q. Xiong, J. L. Abbruzzese, and D. J. McConkey. “Correction: Transforming growth factor α expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines (Cancer Research (2006) 66, 7, (3802-3812)).” Cancer Research 70, no. 2 (January 15, 2010): 852–53. https://doi.org/10.1158/0008-5472.CAN-09-4221.
Pino MS, Shrader M, Baker CH, Cognetti F, Xiong HQ, Abbruzzese JL, et al. Correction: Transforming growth factor α expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines (Cancer Research (2006) 66, 7, (3802-3812)). Cancer Research. 2010 Jan 15;70(2):852–3.
Pino, M. S., et al. “Correction: Transforming growth factor α expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines (Cancer Research (2006) 66, 7, (3802-3812)).” Cancer Research, vol. 70, no. 2, Jan. 2010, pp. 852–53. Scopus, doi:10.1158/0008-5472.CAN-09-4221.
Pino MS, Shrader M, Baker CH, Cognetti F, Xiong HQ, Abbruzzese JL, McConkey DJ. Correction: Transforming growth factor α expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines (Cancer Research (2006) 66, 7, (3802-3812)). Cancer Research. 2010 Jan 15;70(2):852–853.
Published In
Cancer Research
DOI
EISSN
1538-7445
ISSN
0008-5472
Publication Date
January 15, 2010
Volume
70
Issue
2
Start / End Page
852 / 853
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis